Reviewed,
UniProtKB/Swiss-Prot Q16566 (KCC4_HUMAN)
Last modified
November 3, 2009.
Version 94.
History...
Clusters with 100%,
90%,
50% identity |
Documents (7) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Calcium/calmodulin-dependent protein kinase type IV Short name=CaMK IV EC=2.7.11.17 Alternative name(s): CAM kinase-GR | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Complete proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 473 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Calcium/calmodulin-dependent protein kinase belonging to a proposed calcium-triggered signaling cascade. May be involved in transcriptional regulation. May be involved in regulation of microtubule dynamics. In vitro, phosphorylates CREB1, CREBBP, PRM2, MEF2A, MEF2D and STMN1/OP18. May be involved in spermatogenesis. May play a role in the consolidation/retention of hippocampus-dependent long-term memory By similarity. |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. |
| Enzyme regulation | Activated by Ca2+/calmodulin. Binding of calmodulin may releave intrasteric autoinhibition. Must be phosphorylated to be maximally active. Phosphorylated by CAMKK1 or CAMKK2. Autophosphorylation of the N-terminus is required for full activation. In part, activity is independent on Ca2+/calmodulin and autophosphorylation of Ser-336 allows to switch to a Ca2+/calmodulin-independent state By similarity. Probably inactivated by serine/threonine protein phosphatase 2A. |
| Subunit structure | Monomer By similarity. Interacts with serine/threonine protein phosphatase 2A catalytic subunit, PPP2CA or PPP2CB. The interaction with PP2CA or PP2CB is mutually exclusive with binding to Ca2+/calmodulin. |
| Subcellular location | Cytoplasm By similarity. Nucleus By similarity. Note: Substantial localization in certain neuronal nuclei. In spermatids associated with chromatin and nuclear matrix By similarity. |
| Tissue specificity | Expressed in epithelial ovarian cancer tissue. Ref.8 |
| Post-translational modification | Autophosphorylated and phosphorylated by CAMKK1 and CAMKK2 By similarity. Dephosphorylated by serine/threonine protein phosphatase 2A, probably on Thr-200. |
| Sequence similarities | Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. CaMK subfamily. Contains 1 protein kinase domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cytoplasm Nucleus |
| Coding sequence diversity | Polymorphism |
| Ligand | ATP-binding Calcium Calmodulin-binding Nucleotide-binding |
| Molecular function | Kinase Serine/threonine-protein kinase Transferase |
| PTM | Acetylation Phosphoprotein |
| Technical term | 3D-structure Complete proteome |
| Gene Ontology (GO) | |
| Biological process | protein amino acid phosphorylation Ref.1 Traceable author statement. Source: ProtInc signal transduction Ref.1Traceable author statement. Source: ProtInc |
| Cellular component | cytosol Inferred from Experiment. Source: Reactome nucleolusInferred from direct assay. Source: HPA nucleoplasm Ref.5Inferred from Experiment. Source: Reactome |
| Molecular function | ATP binding Inferred from electronic annotation. Source: UniProtKB-KW calcium ion bindingInferred from electronic annotation. Source: UniProtKB-KW calmodulin bindingInferred from electronic annotation. Source: UniProtKB-KW calmodulin-dependent protein kinase activityInferred from electronic annotation. Source: EC |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 473 | 473 | Calcium/calmodulin-dependent protein kinase type IV | PRO_0000086106 | ||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 46 – 300 | 255 | Protein kinase | |||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 52 – 60 | 9 | ATP By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 301 – 340 | 40 | Autoinhibitory domain | |||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 322 – 341 | 20 | Calmodulin-binding Potential | |||||||||||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 164 | 1 | Proton acceptor By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 75 | 1 | ATP By similarity | |||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 12 | 1 | Phosphoserine; by autocatalysis Ref.5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 13 | 1 | Phosphoserine; by autocatalysis Ref.5 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 190 | 1 | N6-acetyllysine Ref.12 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 200 | 1 | Phosphothreonine Ref.5 Ref.9 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 336 | 1 | Phosphoserine; by autocatalysis | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 341 | 1 | Phosphoserine Ref.10 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 360 | 1 | Phosphoserine Ref.10 | |||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 150 | 1 | E → G in a lung adenocarcinoma sample; somatic mutation. Ref.13 | VAR_040604 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 178 | 1 | D → N: dbSNP rs35548075. Ref.13 | VAR_040605 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 465 | 1 | Q → R | VAR_040606 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 469 | 1 | I → M in a lung large cell carcinoma sample; somatic mutation. Ref.13 | VAR_040607 | ||||||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 12 | 1 | S → A: Loss of activity. Ref.5 Ref.9 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 13 | 1 | S → A: Loss of activity. Ref.5 Ref.9 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 320 – 321 | 2 | FN → DD: Loss of interaction with PPP2CA/PPP2CB. Ref.9 | |||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 42 – 44 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 46 – 51 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 58 – 65 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 71 – 78 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 93 – 95 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 104 – 109 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 111 – 118 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 126 – 130 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 138 – 157 | 20 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 167 – 169 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 170 – 176 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 181 – 183 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 210 – 213 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 221 – 226 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 230 – 235 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 248 – 255 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 263 – 268 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 271 – 278 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 285 – 287 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 291 – 296 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 298 – 300 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 311 – 335 | 25 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "cDNA cloning and expression of human calmodulin-dependent protein kinase IV." Kitani T., Okuno S., Fujisawa H. J. Biochem. 115:637-640(1994) [PubMed: 8089075] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "The cDNA sequence and characterization of the Ca2+/calmodulin-dependent protein kinase-Gr from human brain and thymus." Bland M.M., Monroe R.S., Ohmstede C.A. Gene 142:191-197(1994) [PubMed: 8194751] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Cerebellum and Thymus. |
| [3] | "A Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, expressed after transformation of primary human B lymphocytes by Epstein-Barr virus (EBV) is induced by the EBV oncogene LMP1." Mosialos G., Hanissian S.H., Jawahar S., Vara L., Kieff E., Chatila T.A. J. Virol. 68:1697-1705(1994) [PubMed: 8107230] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Blood. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain and Lung. |
| [5] | "A unique phosphorylation-dependent mechanism for the activation of Ca2+/calmodulin-dependent protein kinase type IV/GR." Chatila T., Anderson K.A., Ho N., Means A.R. J. Biol. Chem. 271:21542-21548(1996) [PubMed: 8702940] [Abstract] Cited for: ENZYME REGULATION, PHOSPHORYLATION AT SER-12; SER-13 AND THR-200, MUTAGENESIS OF SER-12 AND SER-13. |
| [6] | "Regulation of microtubule dynamics by Ca2+/calmodulin-dependent kinase IV/Gr-dependent phosphorylation of oncoprotein 18." Melander Gradin H., Marklund U., Larsson N., Chatila T.A., Gullberg M. Mol. Cell. Biol. 17:3459-3467(1997) [PubMed: 9154845] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF STMN1. |
| [7] | "Ca(2+)-dependent gene expression mediated by MEF2 transcription factors." Blaeser F., Ho N., Prywes R., Chatila T.A. J. Biol. Chem. 275:197-209(2000) [PubMed: 10617605] [Abstract] Cited for: FUNCTION IN PHOSPHORYLATION OF MEF2A AND MEF2D. |
| [8] | "Ca(2+)/calmodulin-dependent protein kinase IV expression in epithelial ovarian cancer." Takai N., Miyazaki T., Nishida M., Nasu K., Miyakawa I. Cancer Lett. 183:185-193(2002) [PubMed: 12065094] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [9] | "Regulation and function of the calcium/calmodulin-dependent protein kinase IV/protein serine/threonine phosphatase 2A signaling complex." Anderson K.A., Noeldner P.K., Reece K., Wadzinski B.E., Means A.R. J. Biol. Chem. 279:31708-31716(2004) [PubMed: 15143065] [Abstract] Cited for: ENZYME REGULATION, INTERACTION WITH SERINE/THREONINE PROTEIN PHOSPHATASE 2A, PHOSPHORYLATION AT THR-200, MUTAGENESIS OF 320-PHE-ASN-321. |
| [10] | "Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry." Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R., Keri G., Wehland J., Daub H. Mol. Cell. Proteomics 6:537-547(2007) [PubMed: 17192257] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341 AND SER-360, MASS SPECTROMETRY. |
| [11] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [12] | "Lysine acetylation targets protein complexes and co-regulates major cellular functions." Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., Olsen J.V., Mann M. Science 325:834-840(2009) [PubMed: 19608861] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-190, MASS SPECTROMETRY. |
| [13] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed: 17344846] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] GLY-150; ASN-178; ARG-465 AND MET-469. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D30742 mRNA. Translation: BAA06403.1. L17000 mRNA. Translation: AAA35639.1. L24959 mRNA. Translation: AAA18251.1. BC016695 mRNA. Translation: AAH16695.2. Different initiation. BC025687 mRNA. Translation: AAH25687.1. | |||||||||||||
| IPI | IPI00430411. | ||||||||||||
| PIR | A53036. | ||||||||||||
| RefSeq | NP_001735.1. | ||||||||||||
| UniGene | Hs.591269 | ||||||||||||
3D structure databases | |||||||||||||
| |||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| STRING | Q16566. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q16566. | ||||||||||||
Proteomic databases | |||||||||||||
| PeptideAtlas | Q16566. | ||||||||||||
| PRIDE | Q16566. | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000282356; ENSP00000282356; ENSG00000152495; Homo sapiens. [Genome view] | ||||||||||||
| GeneID | 814. | ||||||||||||
| KEGG | hsa:814. | ||||||||||||
| UCSC | uc003kpf.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 814. | ||||||||||||
| GeneCards | GC05P110587. | ||||||||||||
| H-InvDB | HIX0005080. | ||||||||||||
| HGNC | HGNC:1464. CAMK4. | ||||||||||||
| HPA | CAB004347. HPA011753. HPA017206. | ||||||||||||
| MIM | 114080. gene. | ||||||||||||
| PharmGKB | PA26050. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| HOGENOM | Q16566. | ||||||||||||
| HOVERGEN | Q16566. | ||||||||||||
| OMA | VHEDEPP. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| BRENDA | 2.7.11.17. 247. | ||||||||||||
| Pathway_Interaction_DB | nfat_3pathway. Role of Calcineurin-dependent NFAT signaling in lymphocytes. hdac_classii_pathway. Signaling events mediated by HDAC Class II. pi3kplctrkpathway. Trk receptor signaling mediated by PI3K and PLC-gamma. | ||||||||||||
| Reactome | REACT_11061. Signalling by NGF. REACT_15295. Opioid Signalling. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q16566. | ||||||||||||
| Bgee | Q16566. | ||||||||||||
| CleanEx | HS_CAMK4. | ||||||||||||
| Genevestigator | Q16566. | ||||||||||||
| GermOnline | ENSG00000152495. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR015733. Ca/calmodulin-dep_kinase_4. IPR000719. Prot_kinase_core. IPR017441. Protein_kinase_ATP_BS. IPR017442. Se/Thr_pkinase-rel. IPR008271. Ser_thr_pkin_AS. IPR002290. Ser_thr_pkinase. [Graphical view] | ||||||||||||
| PANTHER | PTHR22982:SF33. CaMKIV. 1 hit. | ||||||||||||
| Pfam | PF00069. Pkinase. 1 hit. [Graphical view] | ||||||||||||
| ProDom | PD000001. Prot_kinase. 1 hit. [Graphical view] [Entries sharing at least one domain] | ||||||||||||
| SMART | SM00220. S_TKc. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other Resources | |||||||||||||
| NextBio | 3300. | ||||||||||||
| PMAP-CutDB | Q16566. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | KCC4_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q16566 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| SIMILARITY comments Index of protein domains and families |

Clusters with


